CLSH CLS Holdings USA

CLS Holdings USA Awarded Non-Provisional U.S. Utility Patent for Cannabidiol Extraction and Conversion Process

CLS Holdings USA Awarded Non-Provisional U.S. Utility Patent for Cannabidiol Extraction and Conversion Process

Continues to Bolster its Intellectual Property Protection

LAS VEGAS, June 13, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH)  “CLS,” a development stage diversified cannabis company operating as Cannabis Life Sciences, is pleased to announce today that it has been awarded a non-provisional U.S. utility patent for cannabidiol extraction and conversion process by the United States Patent and Trademark Office. U.S. patent number 9,950,976 B1.

The patent is directed to a process for the extraction of cannabidiol from any variety of cannabis plants. The extraction process includes a sizing unit wherein raw cannabis plant material is reduced to a uniform size, and a blending unit wherein an extraction solvent is blended together with the cannabis plant material to form an initial extract. The conversion process, wherein the processed extract is combined and processed with an acidic component, involves a separator unit in which solvent is added and a separator organic effluent is obtained.

CLS Chief Executive Jeff Binder commented, “We believe our strong intellectual property differentiates us from many of the operators out there.  We will seek to license our proprietary extraction and conversion methodology to other operators to be able to monetize it and help build long term shareholder value.”

About CLS Holdings USA, Inc.

CLS Holdings USA, Inc. (CLSH) plans to become a diversified cannabis company and is shifting its corporate strategy to becoming a fully licensed integrated cannabis producer and retailer in Nevada and other states.  CLS Holdings USA, Inc. has entered into a definitive agreement to acquire Oasis Cannabis, which is expected to close in the second quarter of 2018.

CLS stands for "Cannabis Life Sciences," in recognition of the Company's patent pending proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.

For additional information, please visit:

Forward Looking Statements

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. These forward-looking statements include, but are not limited to, statements relating to whether certain transactions will be completed, the terms of such transactions, the descriptions of the companies and the business that any potential target companies could bring to CLS Holdings. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these terms or other comparable terminology. These forward-looking statements are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. We cannot guarantee future results, levels of activity or performance and we cannot guaranty that the proposed transactions described in this press release will occur. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered together with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances or to reflect the occurrence of unanticipated events. See CLS Holdings USA’s filing with the SEC for additional details.

Contact Information

Corporate:

Chairman and CEO

Jeff Binder



888-438-9132

Investors:

Hayden IR



917-658-7878

EN
13/06/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLS Holdings USA

Jesse Redmond
  • Jesse Redmond

City Trees Expands into New York

CLS Holdings is a vertically integrated cannabis company with core operations in Nevada. The company owns and operates Oasis cannabis dispensary, one of the leading stores in Las Vegas. CLS also has a state-of-the art extraction and manufacturing facility in Nevada and a suite of top-performing brands. City Trees is CLS’ flagship brand of extracts, oils, tinctures, capsules, pre-rolls, and vapor cartridges. It is Nevada’s top-selling vape brand and according to BDSA is number two in the state by...

Jesse Redmond
  • Jesse Redmond

CLS Restructures Debt, Lowers Borrowing Costs, and Reduces Shares Outs...

CLS Holdings is a vertically integrated operator founded in 2015 in Nevada. The company operates its Oasis dispensary in downtown Las Vegas and has obtained a conditional cannabis consumption lounge permit, with plans to launch in 2024. City Trees is CLS’ extraction and manufacturing business. Products are sold in its Oasis dispensary and through 71 other retail locations in Nevada. City Trees makes cartridges, disposables, dab applicators, custom-blended tinctures, and craft concentrates. CLS h...

 PRESS RELEASE

CLS Holdings USA, Inc to Host Q3, 2022 Financial Results on April 14, ...

CLS Holdings USA, Inc to Host Q3, 2022 Financial Results on April 14, 2022 LAS VEGAS, April 05, 2022 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, will host a webcast on Thursday, April 14, 2022 at 5 p.m. ET to discuss the Company's financial highlights for its third quarter of fiscal year 2022.   Event:CLS Holdings USA, Inc. Q3 FY 2022 Financial Results WebcastDate:Thursday, April 14, 2022Time:5:00 p.m. Eastern TimeWebcast: For interested individuals unable to join the we...

 PRESS RELEASE

CLS Holdings Announces November Financial Results

Las Vegas, Nevada--(Newsfile Corp. - December 11, 2019) - CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH) ("CLS" or the ''Company''), a diversified cannabis company operating as Cannabis Life Sciences, is pleased to report unaudited consolidated revenue of $1.08 million for the month of November 2019. November 2019 Financial HighlightsConsolidated revenue from Oasis Cannabis and City Trees of $1.08 million compared to $0.71 million in November 2018, an increase of 52.8%. Consolidated gross margin of 48.5% compared to 43.5% in November 2018.Record revenue from the Company's Oasis Cannabis d...

 PRESS RELEASE

CLS Holdings Announces November Financial Results

CLS Holdings Announces November Financial Results LAS VEGAS, NV, Dec. 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CLS Holdings USA, Inc. (OTCQB: CLSH, CSE: CLSH) (“CLS” or the ''Company''), a diversified cannabis company operating as Cannabis Life Sciences, is pleased to report unaudited consolidated revenue of $1.08 million for the month of November 2019.   November 2019 Financial Highlights  Consolidated revenue from Oasis Cannabis and City Trees of $1.08 million compared to $0.71 million in November 2018, an increase of 52.8%.  Consolidated gross margin of 48.5% compared to ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch